Thought Leadership

At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.

We call it Thought Leadership.

Articles and White Papers

Service:

Scientific:

Sort by:

14-12-2023

Understanding why the Patient Holds the Key to Successful Drug Development

In this whitepaper, Dr Lisa Campbell, Senior Consultant & Medical Advisor at NDA, explores the benefits and challenges of ensuring patient experiences and priorities to define success
17-05-2023

Releasing the potential of patient and public perspective

This article, co-authored by Dr Lisa Campbell, Medical Advisor at NDA highlights a number of patient and public involvement and engagement (PPIE) initiatives by regulatory agencies and regulatory science centres.
05-05-2021

NDA Webinar: Clinical and Regulatory strategies to avoid pitfalls in clinical trials session 2

In this webinar Dr Steffen Thirstrup, addresses why, when, and how to interact with the regulatory agencies to optimize the success of clinical development of a new medicinal product.
05-05-2021

NDA Webinar: Clinical and Regulatory strategies to avoid pitfalls in clinical trials session 1

In this webinar Dr Steffen Thirstrup, presents the fundamentals of designing a successful clinical trial.
29-06-2017

Have you ever wondered why compliance with regulations is so difficult?

What do we mean when we say ‘safety is everybody’s responsibility’? What is meant by risk-based compliance? What is the basis for an effective safety system?